Andrea Pecorale
Die Suchergebnisse bei Legimi sind auf die vom Nutzer angegebenen Suchkriterien zugeschnitten. Wir versuchen Titel, die für unsere Nutzer von besonderem Interesse sein könnten, durch die Bezeichnung "Bestseller" oder "Neuheit" hervorzuheben. Titel in der Liste der Suchergebnisse können auch sortiert werden - die Sortierauswahl hat Vorrang vor anderen Ergebnissen."

Kategorien

Keine Suchergebnisse

Dr. Pecorale is an accomplished professional in the field of radiopharmaceutical technologies, where he is operating since 1994 (SPECT and PET productions). He obtained his Master's Degree in Chemistry and Pharmaceutical Technologies from the University of Padua in 1993, with a thesis focusing on radiopharmacy. As a member of the Italian Pharmacist Association, he is a registered pharmacist.

Currently, he holds a position at GE HealthCare, where he serves as the PET Manufacturing Manager for Drug Product in Europe. In this capacity, he is responsible for managing a network of PET third-party sites across Europe that produce PET products for neurological, cardiac, and oncological diseases. His role involves ensuring the quality and efficiency of the manufacturing processes within this network.

Dr. Pecorale is also recognized as an author, having published the book "Essence of the PET Radiopharmaceutical Business, A Practical Guide" with Springer in 2022.


Dr. Inzerillo pursued a career dedicated to quality assurance in the radiopharmaceutical industry. She obtained a Master's Degree in Biology from the University of Turin in 1984, laying the foundation for her future endeavors. Until her retirement in 2020, she was an esteemed employee of General Electric (GE) in the Healthcare division, where she served as a Quality Assurance Manager.

Her responsibilities in Quality Assurance encompassed PET and SPECT ready-to-use tracers, cold kits, generators, and contrast media. She played a vital role in developing the annual quality planning, coordinating quality projects, establishing standard operating procedures, and designing training plans extended also to CMOs sites. She was also responsible for validation activities and auditing to ensure compliance with laws, regulations, and guidelines.

Dr. Inzerillo was one of the first quality assurance specialists in Italy to handle the conversion of radiopharmaceuticals into drugs, since 1993.


Dr. Salvadori graduated in chemistry and specialized in nuclear chemistry and radiochemistry. He began his career in 1980 at the CNR Institute of Clinical Physiology in Pisa, where he started the first PET/Cyclotron Centre in Italy. In 2006, he obtained the GMP certification of the site and established an industrial partnership for PET radiotracer manufacturing, becoming the qualified person and the manager of the GMP site. During about 40 years of practice, Dr. Salvadori has gained considerable experience in radiopharmacy and radiopharmaceutical chemistry, with contributions to International conferences, Scientific and Professional Societies, Committees, and Institutional Bodies. He was an expert of the European Pharmacopoeia, and the IAEA. Dr. Salvadori has been active in teaching since 1982. He has published more than 200 scientific papers (peer-reviewed) in the field of Radiopharmacy and Nuclear Medicine, and many book chapters, opinion papers, reviews, state-of-the art articles, and press releases.